MEDICAL DEVICE MANUFACTURING

  • india to offer 20 capital subsidy for domestic production of medtech components

    India to offer 20% capital subsidy for domestic production of medtech components

    ​India is known as the pharmacy of the world because of its generic medicines and low-cost vaccines. It has the highest number of United States Food and Drug Administration (USFDA) compliant Pharma plants outside of the USA. However, in the medical devices sector, the country remains heavily dependent on imports with nearly 70% of the products being sourced from other countries.

Join the community of 2M+ industry professionals

Subscribe to our Daily Newsletter

By continuing you agree to our Privacy Policy & Terms & Conditions

Scan to download App

Download ETHealthworld App for Realtime updates of content you follow

  • Seamless reading experience
  • Save your favourite articles
Advertisement
Advertisement